person

F.H.B.M. S.

Country
The Netherlands
Department
Neurology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 3 partner sites.

Specializations

Cerebrovascular Disorders

The investigator specializes in treating complex brain vessel conditions, with particular emphasis on Cerebral Amyloid Angiopathy (CAA) and intracerebral hemorrhage. Their research focuses on understanding and managing blood vessel disorders affecting the brain.

  • Brain vessel pathologies
  • Hemorrhagic conditions
  • Amyloid-related disorders

Their expertise extends to advanced therapeutic approaches for managing cerebral bleeding and vessel deterioration.

Neuroinflammation

The investigator explores innovative treatments targeting neuroinflammatory processes in brain injuries, particularly focusing on cerebral edema management following hemorrhagic events. Their work involves evaluating novel therapeutic agents to reduce secondary brain injury.

  • Inflammatory responses in brain injury
  • Cerebral edema control
  • Secondary injury prevention

Their research encompasses both acute and chronic neuroinflammatory conditions affecting brain health.

Therapeutic Innovation

The investigator evaluates novel therapeutic approaches for managing cerebrovascular disorders, including targeted protein treatments and anti-inflammatory agents. Their work focuses on developing safer and more effective treatment options for patients with brain vessel diseases.

  • Novel therapeutic agents
  • Protein-targeted treatments
  • Safety and efficacy assessment

Their research aims to advance treatment options for patients with complex cerebrovascular conditions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.